SCHEMBL8059183

SCHEMBL8059183

O=C(O)C(CCc1ccccn1)(c1ccccc1)[PH](=O)O

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.43
CYP2C19 P33261 1/20 0.43
PTPRA P18433 1/20 0.40
HRH1 P35367 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
RAB9A P51151 3/20 0.38
LMNA P02545 1/20 0.38
CYP3A4 P08684 1/20 0.38
NPC1 O15118 2/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8057354 0.86 FDPS (0.44) CYP1A2SMN1; SMN2CYP2C19PTPRATDP1
SCHEMBL8059121 0.76 FDPS (0.47) CYP1A2CYP2C19CYP3A4
SCHEMBL7206606 0.76 CYP1A2 (0.56) CYP1A2SMN1; SMN2CYP2C19PTPRAHRH1
SCHEMBL27461429 0.74 CYP1A2 (0.55) CYP1A2SMN1; SMN2CYP2C19PTPRAHRH1
SCHEMBL8503990 0.73 CYP1A2 (0.70) CYP1A2SMN1; SMN2CYP2C19PTPRAHRH1
SCHEMBL6856046 0.73 CYP1A2 (0.54) CYP1A2SMN1; SMN2CYP2C19PTPRAHRH1
SCHEMBL8878783 0.72 TDP1 (0.51) CYP1A2SMN1; SMN2CYP2C19PTPRAHRH1
SCHEMBL7644315 0.72 GRM2 (0.44) SMN1; SMN2TDP1RAB9ANPC1
SCHEMBL8058494 0.72 CYP2C19 (0.40) SMN1; SMN2CYP2C19TDP1HPGDRAB9A
SCHEMBL7633968 0.72 KIF11 (0.43) CYP1A2CYP2C19TDP1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6046180-A NAALADase inhibitors GUILFORD PHARMACEUTICALS INC. (US) 2000-04-04 US disclosed
EP-0936914-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-08-25 EP disclosed
EP-0936914-A4 1999-08-25 EP disclosed
WO-1997048400-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO disclosed